Compare VATE & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VATE | INGN |
|---|---|---|
| Founded | 1994 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 173.3M |
| IPO Year | 1996 | 2013 |
| Metric | VATE | INGN |
|---|---|---|
| Price | $15.28 | $6.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $11.25 |
| AVG Volume (30 Days) | 55.7K | ★ 336.9K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,246,000,000.00 | $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12.55 | 3.86 |
| 52 Week Low | $3.75 | $5.34 |
| 52 Week High | $16.71 | $9.13 |
| Indicator | VATE | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 45.65 |
| Support Level | $4.48 | $6.03 |
| Resistance Level | N/A | $6.87 |
| Average True Range (ATR) | 1.23 | 0.30 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 77.92 | 37.64 |
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.